Literature DB >> 16497243

Prevalence of Epstein-Barr virus in Japan: trends and future prediction.

Kengo Takeuchi1, Keiko Tanaka-Taya, Yukumasa Kazuyama, Yoichi M Ito, Shuji Hashimoto, Masashi Fukayama, Shigeo Mori.   

Abstract

Epstein-Barr virus (EBV) is the causative agent of infectious mononucleosis and some malignancies including EBV-associated-lymphomas. A large portion of adults all over the world are infected with EBV. In children, however, there are geographic variations. Most of the children in Asia and in other developing countries are infected in their early life, before 1 year of age (>90% of 5-9-year-old children are infected), while the age of primary infection is delayed in Western countries (approx. 50% of 5-9-year-old children are infected). The purpose of the present paper was to investigate the recent time trend of the EBV seropositivity among 5-7-year-old children living in Tokyo and its neighboring prefectures. Indirect immunofluorescein study for IgG antibody to viral capsid antigen was performed on 442 archival sera. Before the early 1990s, >80% of 5-7-year-old children were found to be seropositive, while the positivity rate decreased to 59% (P < 0.001) for the years 1995-1999. These results also showed that the delay in the age of primary infection is continuing and that the rate is estimated to be <50% in 2006. This result suggests that the delay will affect the incidence of EBV-associated disorders in Japan.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497243     DOI: 10.1111/j.1440-1827.2006.01936.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  27 in total

1.  Epstein-Barr virus-associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing.

Authors:  Yasuo Sugita; Mizuhiko Terasaki; Daisuke Niino; Koichi Ohshima; Arakawa Fumiko; Minoru Shigemori; Yasuharu Sato; Naoko Asano
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

Review 2.  Immune modulation during latent herpesvirus infection.

Authors:  Douglas W White; R Suzanne Beard; Erik S Barton
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 3.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 4.  Epstein-barr virus infection and multiple sclerosis: a review.

Authors:  Alberto Ascherio; Kassandra L Munger
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-06       Impact factor: 4.147

5.  Epstein-Barr virus and human herpes virus-8 are not associated with juvenile nasopharyngeal angiofibroma.

Authors:  Román Carlos; Lester D R Thompson; Ana Carolina Netto; Luiz Gustavo Garcia Santos Pimenta; Jeane de Fátima Correia-Silva; Carolina Cavaliéri Gomes; Ricardo Santiago Gomez
Journal:  Head Neck Pathol       Date:  2008-07-01

6.  Features of Epstein-Barr virus reactivation after allogeneic hematopoietic cell transplantation in Korean children living in an area of high seroprevalence against Epstein-Barr virus.

Authors:  Seung Beom Han; E Young Bae; Jae Wook Lee; Pil Sang Jang; Dong-Gun Lee; Nack-Gyun Chung; Dae Chul Jeong; Bin Cho; Soon Ju Lee; Jin Han Kang; Hack-Ki Kim
Journal:  Int J Hematol       Date:  2014-07-01       Impact factor: 2.490

7.  Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia.

Authors:  C Steininger; L Z Rassenti; K Vanura; K Eigenberger; U Jäger; T J Kipps; C Mannhalter; S Stilgenbauer; T Popow-Kraupp
Journal:  Eur J Clin Invest       Date:  2009-06       Impact factor: 4.686

Review 8.  The initiation and prevention of multiple sclerosis.

Authors:  Alberto Ascherio; Kassandra L Munger; Jan D Lünemann
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

9.  Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis.

Authors:  Suzanne L Elliott; Andreas Suhrbier; John J Miles; Greg Lawrence; Stephanie J Pye; Thuy T Le; Andrew Rosenstengel; Tam Nguyen; Anthony Allworth; Scott R Burrows; John Cox; David Pye; Denis J Moss; Mandvi Bharadwaj
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 10.  The role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differences.

Authors:  G Füst
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.